You are here: Home » Current Affairs » Coronavirus » News
Business Standard

Covaxin successfully shipped to 11 cities in India: Bharat Biotech

Bharat Biotech said on Wednesday that it has successfully air-shipped its COVID-19 vaccine Covaxin to 11 cities in India in the early hours

Topics
Coronavirus Vaccine | Bharat Biotech | Coronavirus Tests

Press Trust of India  |  Hyderabad 

Covaxin, bharat biotech, covid, coronavirus, vaccine, drugs, medicine, pharma
It is India's totally indigenous Covid-19 vaccine, developed in collaboration with the Indian Council of Medical Research and National Institute of Virology

said on Wednesday that it has successfully air-shipped its Covid-19 vaccine Covaxin to 11 cities in India in the early hours and that it has donated 16.5 lakh doses to the centre.

The company also expressed its deepest gratitude to the nation, all clinical trial volunteers and its partners for making this a successful and milestone public-private partnership for the development of India's first Covid-19- vaccine, a press release said.

After having received the government purchase order for 55 lakh doses, shipped the first batch of vaccines (each vial containing 20 doses) to Gannavaram (Vijayawada), Guwahati, Patna, Delhi, Kurukshetra, Bangalore, Pune, Bhubaneswar, Jaipur, Chennai and Lucknow.

Covaxin is a highly purified and inactivated two-dose SARS-CoV-2 vaccine, manufactured in a Vero cell manufacturing platform with an excellent safety track record of more than 300 million doses, the release said.

It is India's totally indigenous Covid-19 vaccine, developed in collaboration with the Indian Council of Medical Research and National Institute of Virology.

The inactivated vaccine is developed and manufactured in Bharat Biotech's BSL-3 (Bio-Safety Level 3) biocontainment facility, one of its kind in the world.

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Wed, January 13 2021. 15:41 IST
RECOMMENDED FOR YOU